ICMTek is a Silicon Valley start-up that develops and manufactures custom integrated optical sensing solutions for semiconductor equipment condition monitoring. Founded in 2025 and headquartered in Santa Clara, CA, ICMTek brings over 10 years of incubation through awarded SBIR and STTR government programs. Our mission is to improve yield, uptime, and time to market for IC manufacturing by deploying Fiber Bragg Grating (FBG) sensing technology — a proven platform capable of measuring temperature, strain, and other parameters at up to 100 points along a single optical fiber, saving more than 20× the cost of conventional sensor arrays.
Smart manufacturing is critical for overcoming the technical and economic challenges of scaling to advanced semiconductor nodes. A more complete network of accurate, in-situ, real-time sensors to monitor equipment and wafers is at the heart of this challenge. FBG sensors are immune to RF and microwave electromagnetic interference — making them uniquely suited for plasma etch and deposition chambers where thermocouples and conventional electrical sensors degrade. ICMTek's platform integrates FBG multipoint sensing directly with tool control systems and fab control systems to enable automated process control, chamber matching, fault detection, and predictive maintenance.
ICMTek's leadership team has deep experience spanning semiconductor equipment, fiber optic sensing, enterprise software, and start-up management. The company applies proprietary AI machine learning algorithms and a cloud-based data analytic computing platform to continuously build intelligence from the acoustic and thermal signature libraries captured across deployments. This "Spectrum Broadening" approach deepens the relationship between fabs and their assets — delivering KPIs previously not possible without physically tracking countless individual metrics.
Beyond semiconductors, ICMTek's sensing technologies address structural health monitoring in aerospace, oil and gas pipeline leak detection, power utility arc detection, and medical diagnostics — all markets where passive, EMI-immune, multipoint optical sensing creates measurable value at significantly lower cost than incumbent solutions.